To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DC22863 | FPND |
A novel specific ROCK1 kinase inhibitor with IC50 of 11.2 uM, without inhibitory activity against ROCK2.
More description
|
|
| DC23587 | AMG1 |
A novel specific CRAC channel inhibitor that blocks function of effector but not regulatory T cells in vitro and attenuates the pogression and severity of EAE in vivo.
More description
|
|
| DC21232 | Licogliflozin |
A novel sodium glucose transporter type 1 and type 2 (SGLT1/2) inhibitor for the oral treatment of type 2 diabetes..
More description
|
|
| DC20873 | CCT-031374 hydrobromide |
A novel small-molecule Wnt signaling inhibitor that inhibits TCF-dependent transcription with IC50 of 6.1 uM in 7dF3 reporter assay.
More description
|
|
| DC21426 | NSC654259 |
A novel small molecule Wnt signaling inhibitor that targets the cysteine-rich domain of Frizzled, specifically binds to the Wnt binding site on the Frizzled8 cysteine-rich domain with Kd of 2.9 uM, IC50 of 5.7 uM..
More description
|
|
| DC20389 | GATA4 activator 7 |
A novel small molecule that activates GATA4/NKX2-5 transcriptional synergy with EC50 of 7 uM in cell reporter assay. .
More description
|
|
| DC21330 | MM-206 |
A novel small molecule STAT3 inhibitor that inhibits STAT3 DNA binding activity with IC50 of 1.16 uM, binds to the STAT3 coiled-coil domain (CCD).
More description
|
|
| DC22879 | YK-3-237 |
A novel small molecule sirtuin-1 (SIRT1) activator that reduces acetylation of mutant 53 and exhibits anti-proliferative effects against TNBC cells carrying mutant p53.
More description
|
|
| DC22764 | CS-11 |
A novel small molecule inhibitor that inhibits PP2A and β-catenin interaction by selectively engaging PR55α binding site (Kd=45 pM).
More description
|
|
| DC21680 | Spindlactone B |
A novel small molecule inhibitor of transforming acidic coiled-coil-containing protein 3 (TACC3) that selectively inhibits the nucleation of centrosome microtubules in ovarian cancer cells.
More description
|
|
| DC21679 | Spindlactone A |
A novel small molecule inhibitor of transforming acidic coiled-coil-containing protein 3 (TACC3) that selectively inhibits the nucleation of centrosome microtubules in ovarian cancer cells.
More description
|
|
| DC11817 | Compound L |
A novel small molecule inhibitor of the DNA repair protein Ku70/80, disrupts of Ku70/80-DNA interaction with IC50 of 3.5 uM in EMSA assay.
More description
|
|
| DC25072 | Deltasonamide 1 |
A novel small molecule inhibitor of PDE6δ/KRas interaction with Kd of 203 pM.
More description
|
|
| DC11632 | Cardioprotectant |
A novel small molecule inducer of heme oxygenase-1 that protect human iPSC-derived cardiomyocytes from oxidative stress.
More description
|
|
| DC23772 | CMLD-2 |
A novel small molecule disruptor of HuR-mRNA interaction with Ki of 350 nM.
More description
|
|
| DC22982 | Aldi-6 |
A novel small molecule ALDH inhibitor with IC50 of 600 nM, 800 nM and 1000 nM for ALDH1A1, ALDH2, and ALDH3A1, respectively.
More description
|
|
| DC22961 | ITP-2 |
A novel small molecule activator of Kv 11.1 (hERG) channel (216% over control at 3 uM for hERG1a activation).
More description
|
|
| DC22660 | Tenovin-D3 |
A novel selective, small-molecule inhibitor of sirtuin SITR2 with IC50 of 21.8 uM.
More description
|
|
| DC23749 | Rac1-IN-1 |
A novel selective small molecule Rac1 inhibitor that blocks Rac1-PAK1 complex formation with IC50 of 95±21 nM.
More description
|
|
| DC23742 | Rac1-IN-6 |
A novel selective small molecule Rac1 inhibitor that blocks Rac1-PAK1 complex formation with IC50 of 88±48 nM.
More description
|
|
| DC25071 | PDE6δ inhibitor 8 |
A novel selective small molecule inhibitor of PDE6δ/KRas interaction with Kd of 358 pM..
More description
|
|
| DC22370 | Meptyldinocap |
A novel powdery mildew (Erysiphe necator) fungicide that shows protectant and post-infective activities. .
More description
|
|
| DC23465 | DKR-1051 |
A novel potent, subtype-selective sigma 2 receptor/PGRMC1 ligand with Ki of 61 nM, 9-fold selectivity over sigma 1 receptors (Ki=556 nM).
More description
|
|
| DC23450 | SAS-1121 |
A novel potent, subtype-selective sigma 2 receptor/PGRMC1 ligand with Ki of 16.2 nM, 574-fold selectivity over sigma 1 receptors..
More description
|
|
| DC23487 | AS2575959 |
A novel potent, specific, orally available GPR40 agonist that influences glucose-dependent insulin secretion both in vitro pancreas β-cell-derived cells and in vivo.
More description
|
|
| DC22740 | RO 5126946 |
A novel potent, selective, orally bioavailable and brain-penetran α7nAChR positive allosteric modulator with EC50 of 60 nM.
More description
|
|
| DC21441 | ONO-2952 |
A novel potent, selective, orally active translocator protein 18 kDa (TSPO/PBR) antagonist with Ki of 0.33-9.3 nM for both rat and human TSPO.
More description
|
|
| DC22673 | SCH 486757 |
A novel potent, selective, orally active nociceptin/orphanin FQ peptide (NOP, ORL1) receptor agonist with Ki of 4.6 nM, with high selectiivity over classical opioid receptors.
More description
|
|
| DC20782 | BI 689648 |
A novel potent, selective, orally active aldosterone synthase inhibitor with IC50 of 2 nM, displays 150-fold selectivity over related cortisol synthase.
More description
|
|
| DC20685 | AS2795440 |
A novel potent, selective, oral PIKfyve inhibitor that selectively decreases c-Rel binding to gene promoters of IL-12p40 and IL-1β, regulates cytokine production through PIKfyve-c-Rel pathway ( IL-12p40 IC50=2 nM).
More description
|
|